Leow Jeffrey J, Meyer Christian P, Wang Ye, Chang Steven L, Chung Benjamin I, Trinh Quoc Dien, Korets Ruslan, Bhojani Naeem
1 Division of Urology and Center for Surgery and Public Health , Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
2 Department of Urology, Tan Tock Seng Hospital , Singapore .
J Endourol. 2017 Aug;31(8):742-750. doi: 10.1089/end.2017.0225. Epub 2017 Jul 13.
To investigate the contemporary trends and perioperative outcomes of percutaneous nephrolithotomy (PCNL) by using a population-based cohort.
Using the Premier Healthcare Database, we identified 225,321 patients in whom kidney/ureteral calculi were diagnosed and who underwent PCNL at 447 different hospitals across the United States from 2003 to 2014. Outcomes included 90-day postoperative complications (as classified by the Clavien-Dindo system), prolonged hospital length of stay, operating room time, blood transfusions, and direct hospital costs. Temporal trends were quantified by estimated annual percentage change (EAPC) by using least-squares linear regression analysis. Multivariable logistic regression was performed to identify predictors of outcomes.
PCNL utilization rates initially increased from 6.7% (2003) to 8.9% (2008) (EAPC: +5.60%, p = 0.02), before plateauing at 9.0% (2008-2011), and finally declining to 7.2% in 2014 (EAPC: -4.37%, p = 0.02). Overall (Clavien ≥1) and major complication (Clavien ≥3) rates rose significantly (EAPC: +12.2% and +16.4%, respectively, both p < 0.001). Overall/major complication and blood transfusion rates were 23.1%/4.8% and 3.3%, respectively. Median operating room time and 90-day costs were 221 minutes (interquartile range [IQR] 4) and $12,734 (IQR $9419), respectively. Significant predictors of overall complications include higher Charlson comorbidity index (CCI) (CCI ≥2: odds ratio [OR] 2.08, p < 0.001) and more recent year of surgery (2007-2010: OR 3.20, 2011-2014: OR 4.39, both p < 0.001). Higher surgeon volume was significantly associated with decreased overall (OR 0.992, p < 0.001) and major (OR 0.991, p = 0.01) complications.
Our contemporary analysis shows a decrease in the utilization of PCNL in recent years, along with an increase in complication rates. Numerous patient, hospital, and surgical characteristics affect complication rates.
通过基于人群的队列研究,探讨经皮肾镜取石术(PCNL)的当代趋势和围手术期结局。
利用Premier医疗数据库,我们识别出2003年至2014年期间在美国447家不同医院被诊断为肾/输尿管结石并接受PCNL的225321例患者。结局指标包括术后90天并发症(按照Clavien-Dindo系统分类)、住院时间延长、手术室时间、输血情况以及直接住院费用。通过最小二乘线性回归分析,采用估计年百分比变化(EAPC)对时间趋势进行量化。进行多变量逻辑回归分析以确定结局的预测因素。
PCNL的利用率最初从2003年的6.7%增至2008年的8.9%(EAPC:+5.60%,p = 0.02),之后在2008 - 2011年稳定在9.0%,最终在2014年降至7.2%(EAPC:-4.37%,p = 0.02)。总体(Clavien≥1)和主要并发症(Clavien≥3)发生率显著上升(EAPC分别为+12.2%和+16.4%,p均<0.001)。总体/主要并发症发生率和输血率分别为23.1%/4.8%和3.3%。手术室时间中位数和90天费用分别为221分钟(四分位间距[IQR] 4)和12734美元(IQR 9419美元)。总体并发症的显著预测因素包括较高的Charlson合并症指数(CCI)(CCI≥2:比值比[OR] 2.08,p < 0.001)以及更近的手术年份(2007 - 2010年:OR 3.20,2011 - 2014年:OR 4.39,p均<0.001)。较高的外科医生手术量与总体(OR 0.992,p < 0.001)和主要(OR 0.991,p = 0.01)并发症的减少显著相关。
我们的当代分析表明,近年来PCNL的利用率有所下降,同时并发症发生率有所上升。众多患者、医院和手术特征会影响并发症发生率。